Company Number: 14253244

Analysis Date: 2025-07-20 14:09 UTC

Financial Health Assessment for ALISANMAR LIMITED

---

1. Financial Health Score: D

Explanation:
ALISANMAR LIMITED shows early-stage signs of financial strain, reflected in negative net assets and working capital in the latest financial year. With no turnover reported and increasing current liabilities surpassing current assets, the company is exhibiting symptoms akin to financial "distress" in medical terms. While the company is still active and has no overdue filings, its financial "vital signs" warrant close monitoring and proactive intervention.

---

2. Key Vital Signs

Metric	2024 (£)	Interpretation
Turnover	0	No revenue generated, indicating no trading activity
Current Assets	9,246	Cash or receivables available to cover short-term debts
Current Liabilities	10,876	Debts and obligations due within one year
Net Current Assets	-1,629	Working capital deficit; current liabilities exceed assets
Net Assets (Shareholder Equity)	-1,629	Negative net worth; liabilities exceed total assets
Average Number of Employees	0	No staff employed, may indicate minimal operations

• Negative Net Current Assets: This is a critical "symptom" showing the company’s inability to cover short-term debts with short-term assets, a sign of liquidity stress.
• Negative Net Assets: Indicates the company’s total liabilities have surpassed total assets, a red flag analogous to an “imbalanced vital system” in a patient.
• No Revenue: The absence of turnover suggests the company is either dormant in operations or has not yet commenced trading, which is common in newly incorporated companies but risky if prolonged.
• No Employees: No workforce presence may limit operational capacity or indicate a holding or non-trading entity.

---

3. Diagnosis

ALISANMAR LIMITED is currently in a precarious financial condition characterized by a lack of trading activity and a working capital deficit. The company has moved from positive net assets (£1,764 in 2023) to a negative position (-£1,629 in 2024), showing a deterioration in financial health within one year. This could be due to accruing liabilities without corresponding asset growth or income generation.

The "symptoms" suggest the company is either in the startup phase without revenue or is incurring costs (possibly setup or administrative) that are eroding its equity base. Without intervention, the negative working capital may lead to cash flow crises, impeding the company’s ability to meet short-term obligations.

---

4. Recommendations

Immediate Actions:

• Revenue Generation: Prioritize initiating or ramping up trading activities to generate turnover and improve cash inflows.
• Cost Management: Review and reduce overheads or discretionary expenses to preserve cash and stabilize working capital.
• Cash Flow Monitoring: Implement rigorous cash flow forecasting to anticipate liquidity needs and avoid insolvency risks.
• Funding Options: Consider seeking additional capital injection from the shareholder (who has full control) or external sources to restore positive net assets.
• Review Liabilities: Negotiate terms with creditors to extend payment periods or reduce liabilities, aiming to balance current assets and liabilities.

Strategic Actions:

• Business Plan Review: Reassess the business model and operational strategy to align expenditures with realistic revenue projections.
• Compliance and Reporting: Maintain timely filing of accounts and confirmation statements to avoid penalties and demonstrate good governance.
• Professional Advice: Engage financial and legal advisors to support restructuring or turnaround plans if trading difficulties persist.

---

Medical Analogy Summary:
ALISANMAR LIMITED currently exhibits "symptoms of financial distress" with a negative working capital "pulse" and declining "net asset health." Without a "treatment plan" involving revenue generation and cost control, the company risks "financial failure." Early intervention is crucial to restore "financial vitality" and ensure sustainable operations.

---